Update on the use of dutasteride in the management of benign prostatic hypertrophy
Joe Miller, Thomas H TarterDivision of Urology, Southern Illinois University School of Medicine, Springfield, IL, USAAbstract: Benign prostatic hyperplasia (BPH) is a frequent cause of lower urinary symptoms, with a prevalence of 50% by the sixth decade of life. Hyperplasia of stromal and epithelial...
Guardado en:
Autores principales: | Joe Miller, Thomas H Tarter |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0ff1dce861134cfd9c3abd9be8d3c16b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Combination therapy with dutasteride and tamsulosin for the treatment of symptomatic enlarged prostate
por: J Miller, et al.
Publicado: (2009) -
The safety and efficacy of aspirin intake in photoselective vaporization laser treatment of benign prostate hyperplasia
por: Shao IH, et al.
Publicado: (2013) -
Comment: update on the management of constipation in the elderly: new treatment options
por: Lee Techner
Publicado: (2010) -
Is it necessary to cure prostate cancer when it is possible? (Understanding the role of prostate inflammation resolution to prostate cancer evolution)
por: Ronald E Wheeler
Publicado: (2007) -
Rivastigmine in the treatment of Alzheimer's disease: an update
por: Maria Luisa Onor, et al.
Publicado: (2007)